When probenecid was administered to mice with CKD to increase uremic metabolite levels and AHR activation in skeletal muscle further, deletion of the AHR was found to have sex-dependent and fuel source–dependent effects on muscle mitochondrial OXPHOS. Here, AHR is linked to chronic kidney disease.